insights_auto
Why is TCE2 down 4.22%?
Dive Deeperchevron_right
TCE2:FRA
Celldex Therapeutics Inc
€25.67
arrow_downward
-4.22%(-1.13) 1D
Oct 9, 10:00:00 PM GMT+2 · EUR
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for TCE2...
Open
€25.67
High
€25.67
Low
€25.67
Mkt. cap
2.35B
Avg. vol.
29.00
Volume
0.00
52-wk high
€38.34
52-wk low
€18.90
No. of employees
198
Open
€25.67
High
€25.67
Low
€25.67
Mkt. cap
2.35B
Avg. vol.
29.00
Volume
0.00
52-wk high
€38.34
52-wk low
€18.90
No. of employees
198
News stories
From web sources and news partners
Yahoo Finance
·
6 hours ago
A COVID Vaccine Stock on the S&P 500 Is Up 600% This Year
24/7 Wall St.
·
19 hours ago
Why "VOO and Chill" Lost Money for 8 Straight Years: What $100,000 in the S&P 500 Did From 2000 to 2008
Seeking Alpha
·
13 hours ago
The 1-Minute Market Report October 10, 2026 (NYSEARCA:VOO)
Investor's Business Daily
·
2 hours ago
Futures: 6 Stocks Near Buy Points; Big Earnings, Inflation Data Due
About Celldex Therapeutics Inc
CEO-
Employees198
Founded1983
HeadquartersHampton, New Jersey, United States
SectorBiotechnology
Websitecelldex.com